AlanSubie4Life
Efficiency Obsessed Member
Actually this is still good news (it has been extremely poorly reported in the press - though the NY Times updated their extremely poorly written "take" from this morning). It's definitely prudent for Moderna to start the process of creating a booster that provides a more strongly neutralizing response to a virus with a more optimal RBD (receptor binding domain), but overall it is still good news:
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
B.1.351 is the South African variant which is of the most concern:
"Importantly, the VSV PsVN GMT of these human sera to the full B.1.351 spike variant was still 1/290, with all evaluated sera able to fully neutralize."
So, the vaccine is still effective enough against this variant - though the level of reduction in neutralizing activity is nearly sufficient to initiate a change in the vaccine.
The question is: How much more optimal can the changes to the receptor binding domain get? That's the change that's occurring in this virus, which allows it to latch on more securely - the N501Y mutation. (Inside the B.1.1.7 Coronavirus Variant ) It may be at this point that further changes have dramatically lower competitive advantage over this initial mutation (and there appears to be convergent evolution occurring resulting in this similar mutation in several different strains - including one in California, which implies it may be close to optimal). That would mean there may not be much more evolutionary drive to create further changes which would result in an even lower neutralization GMT (geometric mean titer). That's what I'm hoping!
If the antibodies generated by the vaccine are still numerous enough and a close enough match to latch onto the spike protein and prevent binding to cells, and that appears to be the case, that is good news, for now. At least that's my layman's impression.
The bigger danger is once vaccination becomes more widespread, there's going to be a competitive advantage to variants that manage to directly escape this immune response. We haven't really seen that evolutionary driving force become widespread, yet (we do see it to some extent if people are getting reinfected, probably, but those cases seem rare). (Though there is some thought that some of these variants have been driven rapidly by exactly that - rapid evolution of the virus in a compromised individual who cannot clear the infection - so the virus continues to optimize against any immune response that may be present - this theory (and it's just a theory) is supported by analysis of the genome, which shows up as a branch in the tree with MANY mutations that built up rapidly, which isn't something that typically occurs).
All the more reason to get as many people vaccinated as possible, and also to continue to apply strong suppression techniques to drive infections to zero. We still need to cut off transmission! Otherwise we are opening ourselves up to variants which escape the vaccine. The more transmission, the higher the risk of this happening. N95s for all!!!
I was finally able to order medical-grade 3M N95s on eBay, for my parents, FWIW. So that's good. It's about f'ing time! I don't think medical grade is necessary, really; the standard N95 should be fine (it's about a factor of 2 difference in price), but I got the medical grade because the straps seemed more robust (elastic plus fabric) rather than the straight elastic bands on the non-medical grade N95. Hopefully they're legit (but I'm optimistic they are).
Last edited: